Newcastle medical expertise agency QuantuMDx has launched an up to date moveable testing system that may detect Covid, forward of probably winter strain on well being providers.
The corporate, which final 12 months secured £15m enterprise capital funding, has revealed its newest Q-POC respiratory panel check which might detect different infectious ailments.
QauntuMDx’s workforce has developed the brand new check to incorporate essentially the most up-to-date data on sequences of SARS-CoV-2, Flu A, Flu B & RSV viruses. Respiratory panel exams detect pathogens within the lungs, nostril, and throat.
Learn extra: go right here for extra North East enterprise information
Jonathan O’Halloran, chief govt officer of QuantuMDx, stated: “The recent Covid-19 pandemic highlighted the need for rapid high quality PCR panels to accurately diagnose infectious diseases and so I am pleased to announce the launch of this new QuantuMDx PCR respiratory panel today.
“The panel, which can detect SARS-CoV-2, Flu A, Flu B and RSV at the point of need, is capable of returning accurate test results in 35 minutes.
“The system offers a simple ‘one sample, one test’ process, run on the portable Q-POC platform, which can be operated by any healthcare professional after basic training, differentiating it from many competitor models on the market.
“With the coming winter likely to bring parallel pressure from these viruses, on-demand rapid accurate PCR testing offered by this new assay on the Q-POC platform has the potential to provide clinicians with an optimum solution for respiratory infection control.
“At QuantuMDx, we are committed to making transformative, quality rapid diagnosis accessible to everyone, so that diseases can be detected and treated earlier. The launch of this new assay is an exemplar of our strategy to create multiplex, rapid syndromic panel tests, at the point of need and is credit to the incredible team at QuantuMDx. I look forward to continuing to work with them as we continue to add to our menu of tests for Q-POC and deliver some truly disruptive multiplex tests for the point of need in minutes.”
In 2020 QuantuMDx introduced it was embarking on an £11m world scale-up plan which included investing in mass manufacture of its Q-POC gadget – the hand held system that goals to offer diagnoses for a spread of diseases, notably in poorer nations the place there’s restricted entry to hospitals and laboratories.